| XACT noncoding RNA competes with XIST in the control of X chromosome activity during human early development C Vallot, C Patrat, AJ Collier, C Huret, M Casanova, TML Ali, M Tosolini, ... Cell stem cell 20 (1), 102-111, 2017 | 192 | 2017 |
| XACT, a long noncoding transcript coating the active X chromosome in human pluripotent cells C Vallot, C Huret, Y Lesecque, A Resch, N Oudrhiri, ... Nature genetics 45 (3), 239-241, 2013 | 176 | 2013 |
| The Ftx noncoding locus controls X chromosome inactivation independently of its RNA products G Furlan, NG Hernandez, C Huret, R Galupa, JG van Bemmel, A Romito, ... Molecular cell 70 (3), 462-472. e8, 2018 | 96 | 2018 |
| Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice C Huret, D Desjardins, M Miyalou, B Levacher, MA Zin, O Bonduelle, ... Vaccine 31 (11), 1540-1547, 2013 | 45 | 2013 |
| DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies B Bellier, C Huret, M Miyalou, D Desjardins, MP Frenkiel, P Despres, ... Vaccine 27 (42), 5772-5780, 2009 | 39 | 2009 |
| Recombinant retrovirus‐like particle forming DNA vaccines in prime‐boost immunization and their use for hepatitis C virus vaccine development D Desjardins, C Huret, C Dalba, F Kreppel, S Kochanek, FL Cosset, ... The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2009 | 39 | 2009 |
| A primate-specific retroviral enhancer wires the XACT lncRNA into the core pluripotency network in humans M Casanova, M Moscatelli, LÉ Chauvière, C Huret, J Samson, ... Nature Communications 10 (1), 5652, 2019 | 27 | 2019 |
| Efficacy of DNA vaccines forming e7 recombinant retroviral virus-like particles for the treatment of human papillomavirus-induced cancers G Lescaille, F Pitoiset, R Macedo, C Baillou, C Huret, D Klatzmann, ... Human gene therapy 24 (5), 533-544, 2013 | 24 | 2013 |
| Early transcriptome signatures from immunized mouse dendritic cells predict late vaccine-induced T-cell responses N Dérian, B Bellier, HP Pham, E Tsitoura, D Kazazi, C Huret, ... PLOS Computational Biology 12 (3), e1004801, 2016 | 16 | 2016 |
| Species-specific regulation of XIST by the JPX/FTX orthologs O Rosspopoff, E Cazottes, C Huret, A Loda, AJ Collier, M Casanova, ... Nucleic Acids Research 51 (5), 2177-2194, 2023 | 8 | 2023 |
| Mechanistic diversification of XIST regulatory network in mammals O Rosspopoff, C Huret, AJ Collier, M Casanova, PJ Rugg-Gunn, ... BioRxiv, 689430, 2019 | 7 | 2019 |
| Altered X-chromosome inactivation predisposes to autoimmune manifestations in mice C Huret, A David, M Mohamed, N Valentin, F Charlotte, M Goodhardt, ... bioRxiv, 2023.04. 20.537662, 2023 | 2 | 2023 |
| Noncoding RNA Competes with in the Control of X Chromosome Activity during Human Early Development C Vallot, C Patrat, AJ Collier, C Huret, M Casanova, L Ali, M Tosolini, ... Elsevier, 2017 | | 2017 |
| Développement d’une stratégie d’immunothérapie dans le traitement des cancers des voies aéro-digestives supérieures induits par des papillomavirus G Lescaille, F Pitoiset, R Macedo, C Huret, C Baillou, B Bellier, F Lemoine 59ème Congrès de la SFMBCB, 03013, 2012 | | 2012 |
| Efficacy of DNA Vaccine Encoding Retrovirus-Based VLP to Induce Potent Mucosal and Systemic Immune Responses and Its Use for HIV Vaccination L Torrieri-Dramard, F Pitoiset, C Huret, D Desjardins, D Klatzmann, ... AIDS RESEARCH AND HUMAN RETROVIRUSES 27 (10), A104-A104, 2011 | | 2011 |
| Vaccine strategy based on DNA vaccines forming E7 recombinant retrovirus-like particles for the treatment of HPV-induced head and neck cancers G Lescaille, F Pitoiset, C Huret, FM Lemoine, B Bellier HUMAN GENE THERAPY 22 (6), A12-A13, 2011 | | 2011 |
| P13. Vaccine strategies based on plasmo virus like particles for the treatment of HPV-induced head and neck cancers G Lescaille, F Pitoiset, C Huret, F Lemoine, B Bellier Oral Oncology 1 (47), S78, 2011 | | 2011 |
| Efficacy of a New Generation of DNA-Vaccines Encoding Retrovirus-Based Virus-Like Particles to Induce Both Cellular and Humoral Immune Responses and Its Use for Antiviral … C Huret, M Miyalou, L Torrieri, D Desjardins, C Dalba, D Klatzmann, ... HUMAN GENE THERAPY 21 (6), 783-784, 2010 | | 2010 |
| Efficacy of a new generation of DNA-vaccine encoding retrovirus-based virus-like particles to induce both cellular and humoral immune responses and its HCV-vaccine development D Desjardins, C Huret, P Garrone, B Clerc, L Torrieri, X Dervillez, ... HUMAN GENE THERAPY 19 (10), 1090-1090, 2008 | | 2008 |
